Excimer Laser Trabeculostomy Glaucoma Treatment Study
NCT: NCT04899063 · COMPLETED
NCT IDNCT04899063
StatusCOMPLETED
Start Date2021-05-10
Completion2025-07-29
SponsorElios Vision, Inc. (INDUSTRY)
First posted
Last updated
Brief Summary
Evaluation of the safety and effectiveness of the ELIOS System procedure to reduce intraocular pressure (IOP) in adult subjects with mild to moderate primary open-angle glaucoma (POAG) undergoing cataract surgery
Frequently Asked Questions
What is Excimer Laser Trabeculostomy Glaucoma Treatment Study?
Excimer Laser Trabeculostomy Glaucoma Treatment Study is a clinical trial registered under NCT04899063. Current status: COMPLETED.
What is the status of NCT04899063?
The current status of NCT04899063 (Excimer Laser Trabeculostomy Glaucoma Treatment Study) is: COMPLETED.
When did Excimer Laser Trabeculostomy Glaucoma Treatment Study start?
Excimer Laser Trabeculostomy Glaucoma Treatment Study started on 2021-05-10.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.